novo nordisk mash - Search News

Order byBest matchMost fresh

News

Novo Nordisk, MASH and GLP-1

Novo’s Wegovy becomes first GLP-1 drug approved for MASH

The FDA clearance sets Novo’s medicine up a market battle with Madrigal Pharmaceuticals’ fast-selling Rezdiffra.

Continue reading

Fierce Pharma · 5h

Novo's Wegovy picks up 3rd indication with key FDA approval in the liver disease MASH

pharmaphorum · 10h

Novo Nordisk claims first GLP-1 approval in MASH

2h

Novo Nordisk's Loss Is Eli Lilly's Gain, And Vice Versa

Novo Nordisk A/S gains momentum with FDA approval for Wegovy and strategic pricing. Click for why Novo outshines Eli Lilly ...

4don MSN

Is Novo Nordisk facing its “Nokia moment”? Stock tumbles to $50 from a year-high of $139 amid disruptive rivals and shifting market forces

Novo Nordisks stock has tumbled from record highs after slashing its 2025 outlook, as fierce competition, leadership changes, ...

4d

The Zacks Analyst Blog Highlights Broadcom, Philip Morris International and Novo Nordisk

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results